Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia

International Journal of Cancer

Volumn 118, Issue 10, 2006, Pages 2632-2635

  Dal Maso, Luigino ^a   Zucchetto, Antonella ^a   Tavani, Alessandra ^b   Montella, Maurizio ^c   Ramazzotti, Valerio ^d   Polesel, Jerry ^a   Bravi, Francesca ^b   Talamini, Renato ^a   La Vecchia, Carlo ^b,e   Franceschi, Silvia ^f  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF MILAN   (Italy)

^f INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Benign prostatic hyperplasia; Case control study; Physical activity

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; CASE CONTROL STUDY; CELL HETEROGENEITY; CORRELATION ANALYSIS; EDUCATION; HISTOPATHOLOGY; HOSPITAL ADMISSION; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCUPATIONAL HAZARD; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECREATION; RISK ASSESSMENT; SOCIOECONOMICS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); EXERCISE; HUMANS; MALE; MIDDLE AGED; OCCUPATIONS; ODDS RATIO; PROSTATIC HYPERPLASIA; RECREATION; RISK FACTORS; SOCIAL CLASS;

EID: 33646402345     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21668     Document Type: Article

References (30)

1. Thorpe A, Neal D. Benign prostatic hyperplasia. Lancet 2003;361:1359-67.
2. Neuhouser ML, Kristal AR, Penson DF. Steroid hormones and hormone-related genetic and lifestyle characteristics as risk factors for benign prostatic hyperplasia: review of epidemiologic literature. Urology 2004;64:201-11.
3. Seitter WR, Barrett-Connor E. Cigarette smoking, obesity, and benign prostatic hypertrophy: a prospective population-based study. Am J Epidemiol 1992;135:500-3.
4. Signorello LB, Tzonou A, Lagiou P, Samoli E, Zavitsanos X, Trichopoulos D. The epidemiology of benign prostatic hyperplasia: a study in Greece. BJU Int 1999;84:286-91.
5. Crispo A, Talamini R, Gallus S, Negri E, Gallo A, Bosetti C, La Vecchia C, Dal Maso L, Montella M. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia. Urology 2004;64:717-22.
6. Zucchetto A, Tavani A, Dal Maso L, Gallus S, Negri E, Talamini R, Franceschi S, Montella M, La Vecchia C. History of weight and obesity through life and risk of benign prostatic hyperplasia. Int J Obesity 2005;29:798-803.
7. Lagiou P, Wuu J, Trichopoulou A, Hsieh C-C, Adami H-O, Trichopoulos D. Diet and benign prostatic hyperplasia: a study in Greece. Urology 1999;54:284-90.
8. Lacey JV Jr, Deng J, Dosemeci M, Gao Y-T, Mostofi FK, Sesterhenn IA, Xie T, Hsing AW. Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China. Int J Epidemiol 2001;30:341-9.
9. Gann PH, Hennekens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995;26:40-9.
10. Meigs JB, Mohr B, Barry MJ, McNaughton Collins M, McKinlay JB. Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2001;54:935-44.
11. Platz EA, Kawachi I Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Giovannucci E. Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998;158:2349-56.
12. Breslow NE, Day NE. Statistical Methods in Cancer Research, vol. I. The analysis of case-control studies. Lyon, France: IARC Scientific Publication No. 32, 1980.
13. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factor using case-control data. Am J Epidemiol 1985;122:904-14.
14. Pierotti B, Altieri A, Talamini R, Montella M, Tavani A, Negri E, Franceschi S, La Vecchia C. Lifetime physical activity and prostate cancer risk. Int J Cancer 2005;114:639-42.
15. Zeegers MPA, Dirx MJM, van den Brandt PA. Physical activity and the risk of prostate cancer in the Netherlands Cohort Study, results after 9.3 years of follow-up. Cancer Epidemiol Biomarkers Prev 2005;14:1490-5.
16. Roberts RO, Jacobson DJ, Rhodes T, Klee GG, Lieber MM, Jacobsen SJ. Serum sex hormones and measures of benign prostatic hyperplasia. Prostate 2004;61:124-31.
17. Ross RK, Schottenfeld D. Prostate Cancer. In: Schottenfeld D, Fraumeni JF, eds. Cancer epidemiology and prevention. New York: Oxford University Press, 1996.
18. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. Prospective study of sex hormone levels and risk of prostate cancer J Natl Cancer Inst 1996;88:1118-26.
19. IARC. IARC Handbooks on cancer prevention: weight control and physical activity, vol. 6. Lyon: IARC, 2002.
20. Hammarsten J, Högstedt B. Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999;8:29-36.
21. Mantzoros CS, Tzonou A, Signorello LB, Stampfer M, Trichopoulos D, Adami H-O. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia. Br J Cancer 1997;76:1115-8.
22. Chokkalingam AP, Gao Y-T, Deng J, Stanczyk FZ, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW. Insulin-like growth factors and risk of benign prostatic hyperplasia. Prostate 2002;52:98-105.
23. Roberts RO, Jacobson DJ, Girman CJ, Rhodes T, Klee GG, Lieber MM, Jacobsen SJ. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and urologic measures of benign prostatic hyperplasia. Am J Epidemiol 2003;157:784-91.
24. McTiernan A, Sorensen B, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Rudolph RE, Stanczyk FZ, Schwartz RS, Potter JD. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial. Cancer Epidemiol Biomarkers Prev 2005;14:1020-1.
25. Kirby RS. The natural history of benign prostatic hyperplasia: what have we learned in the last decade? Urology 2000;56(Suppl 5A):3-6.
26. Guess HA. Benign prostatic hyperplasia: antecedents and natural history. Epidemiol Rev 1992;14:131-53.
27. Begg CB. Methodological issues in studies of the treatment, diagnosis, and etiology of prostate cancer. Semin Oncol 1994;21:569-79.
28. Slattery ML, Jacobs DR Jr. Assessment of ability to recall physical activity of several years ago. Ann Epidemiol 1995;5:292-6.
29. Falkner KL, Trevisan M, McCann SE. Reliability of recall of physical activity in the distant past. Am J Epidemiol 1999;150:195-205.
30. Schechtman KB, Barzilai B, Rost K, Fisher EB Jr. Measuring physical activity with a single question. Am J Public Health 1991;81:771-3.